Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Dynacure
481
Dynacure
Technology
Biotechnology
Dynacure develops new treatments for serious orphan disorders, such as Centronuclear Myopathies.
Suggest edits
Raised
$55M
Follow us
Companies in the same industry
TauRx Pharmaceuticals
SIRION BIOTECH
Oxford Immunotec
BioBehavioral Diagnostics
BlueWillow Biologics (NanoBio)
Provia Laboratories
Biognosys Racing Team & Friends
HealthCare Royalty Partners
Ablexis
Apieron
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$55,000,000
Venture capital (Series C) - 2020
Bpifrance
Perceptive Advisors
Tekla Capital Management
+3
Team Size
1–10
Employees
I work here
Location
France
Headquarters
Explore France
$55,000,000
Venture capital (Series C)
Xconomy
Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic
